跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 578 条关于
“ARGO HT”
全部
578
临床试验
288
药物
178
机构
11
资讯
101
去年
Alamar Biosciences Partners with SciLifeLab to Advance Precision Proteomics for Early Disease Detection
8个月前
Alamar Biosciences Secures $50M+ Financing to Advance Precision Proteomics Platform for Early Disease Detection
去年
Alzheimer's Drug Discovery Foundation Invests Record $10M in Alamar Biosciences for Blood-Based Diagnostic Platform
去年
Hoth Therapeutics Strengthens Intellectual Property Portfolio with New Patent Filings for HT-001 and HT-KIT
去年
Argo Biopharma and Novartis Expand Partnership with $5.2 Billion Cardiovascular siRNA Deal
去年
Novartis Secures $5.2 Billion Licensing Deal with China's Argo for RNAi Cardiovascular Therapies
6个月前
Argo Biopharma Strengthens Leadership with Appointment of Dr. Gena Wang as CFO and Chief Strategy Officer
去年
Hoth Therapeutics' HT-001 Demonstrates 100% Success in Phase 2a Trial for Cancer Treatment Skin Toxicities
去年
Argo Biopharma Advances siRNA Therapy BW-40202 to Phase II Trial for Paroxysmal Nocturnal Hemoglobinuria
7个月前
Argo Biopharma's siRNA Therapeutic BW-20829 Enters Phase 2b Trial for Elevated Lipoprotein(a) and Cardiovascular Disease
第 1 页,共 11 页
上一页
下一页